NCT06674967 is a clinical trial in Atrio-Ventricular Block, sponsored by Assiut University.

Who is sponsoring NCT06674967?

NCT06674967 is sponsored by Assiut University.

What condition does NCT06674967 study?

NCT06674967 studies Atrio-Ventricular Block.

Is NCT06674967 still recruiting?

NCT06674967 is currently not yet recruiting. Last updated 5 November 2024.

Last reviewed 2024-11-05 · How we verify

NCT06674967

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Efficacy and Safety of Left Bundle Area Pacing Vs Right Ventricular Apical Pacing in Patients with Atrioventricular Block

Not yet recruiting Last updated 5 November 2024

What this trial tests

trial in Atrio-Ventricular Block in 42 participants. Not yet recruiting.

Timeline

30 November 2024

Primary endpoint
31 August 2026

1 August 2027

Quick facts

Lead sponsor	Assiut University
Status	Not yet recruiting
Study type	OBSERVATIONAL
Enrollment	42
Start date	30 November 2024
Primary completion	31 August 2026
Estimated completion	1 August 2027
Sites	1 location across Egypt

Conditions studied

Atrio-Ventricular Block — all drugs for Atrio-Ventricular Block →

Sponsor

Assiut University

Who can join

Eligibility, any sex, with Atrio-Ventricular Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will address whether LBBaP is superior to RVAP in terms of safety and efficacy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Assiut University trials

Trials by the same sponsor.

NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06674967 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Assiut University
Last refreshed: 5 November 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06674967.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing